Economic burden of skin cancer in Southern Iran: A cost-of-illness study

IF 2 Q3 HEALTH POLICY & SERVICES
Faride Sadat Jalali , Khosro Keshavarz , Mozhgan Seif , Abdosaleh Jafari , Ramin Ravangard
{"title":"Economic burden of skin cancer in Southern Iran: A cost-of-illness study","authors":"Faride Sadat Jalali ,&nbsp;Khosro Keshavarz ,&nbsp;Mozhgan Seif ,&nbsp;Abdosaleh Jafari ,&nbsp;Ramin Ravangard","doi":"10.1016/j.jcpo.2025.100602","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Skin cancer is one of the most common cancers around the world, which imposes a great economic burden on patients and societies. The present study aimed at determining the economic burden of skin cancer in patients referred to diagnostic and treatment centers in southern Iran in 2021.</div></div><div><h3>Methods</h3><div>This was a partial economic evaluation of the cost-of-illness type conducted from the societal perspective with the bottom-up and prevalence-based approaches. A total of 108 patients were included through the simple random sampling method, and a researcher-made data collection form was used to collect the required data. The data on direct medical costs were obtained by using the patient’s medical and financial records, as well as the data on direct medical and indirect costs were collected by asking the patients or their companions on the phone.</div></div><div><h3>Results</h3><div>The results showed that the annual cost of each skin cancer patient in the studied sample was 7699.76 USD in 2021. The indirect costs accounted for the largest share of costs (72.85 %), of which the costs of premature death were the highest. The costs of direct medical and direct non-medical costs were 19.77 % and 7.38 %, respectively, and the economic burden of the disease in the country was estimated at 569,550,508 USD in that year.</div></div><div><h3>Conclusions</h3><div>The economic burden of skin cancer in Iran is very high. Some suggestions to reduce its costs and economic burden include providing specialized services in high-incidence cities, virtual follow-ups, screening services, and sun safety interventions.</div></div>","PeriodicalId":38212,"journal":{"name":"Journal of Cancer Policy","volume":"45 ","pages":"Article 100602"},"PeriodicalIF":2.0000,"publicationDate":"2025-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cancer Policy","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2213538325000463","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEALTH POLICY & SERVICES","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Skin cancer is one of the most common cancers around the world, which imposes a great economic burden on patients and societies. The present study aimed at determining the economic burden of skin cancer in patients referred to diagnostic and treatment centers in southern Iran in 2021.

Methods

This was a partial economic evaluation of the cost-of-illness type conducted from the societal perspective with the bottom-up and prevalence-based approaches. A total of 108 patients were included through the simple random sampling method, and a researcher-made data collection form was used to collect the required data. The data on direct medical costs were obtained by using the patient’s medical and financial records, as well as the data on direct medical and indirect costs were collected by asking the patients or their companions on the phone.

Results

The results showed that the annual cost of each skin cancer patient in the studied sample was 7699.76 USD in 2021. The indirect costs accounted for the largest share of costs (72.85 %), of which the costs of premature death were the highest. The costs of direct medical and direct non-medical costs were 19.77 % and 7.38 %, respectively, and the economic burden of the disease in the country was estimated at 569,550,508 USD in that year.

Conclusions

The economic burden of skin cancer in Iran is very high. Some suggestions to reduce its costs and economic burden include providing specialized services in high-incidence cities, virtual follow-ups, screening services, and sun safety interventions.
伊朗南部皮肤癌的经济负担:一项疾病成本研究
皮肤癌是世界上最常见的癌症之一,给患者和社会带来了巨大的经济负担。本研究旨在确定2021年在伊朗南部诊断和治疗中心转诊的皮肤癌患者的经济负担。方法采用自下而上和基于患病率的方法,从社会角度对疾病类型的成本进行部分经济评价。采用简单随机抽样方法,共纳入108例患者,采用研究者自行制作的资料收集表收集所需资料。直接医疗费用数据通过患者的医疗和财务记录获得,直接医疗费用和间接医疗费用数据通过电话询问患者或其同伴收集。结果研究样本中每名皮肤癌患者在2021年的年费用为7699.76美元。间接成本所占比例最大(72.85 %),其中过早死亡成本最高。直接医疗费用和直接非医疗费用分别为19.77 %和7.38 %,该年该国疾病的经济负担估计为569,550,508美元。结论伊朗皮肤癌经济负担较高。减少其成本和经济负担的建议包括在高发城市提供专门服务、虚拟随访、筛查服务和日光安全干预。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Cancer Policy
Journal of Cancer Policy Medicine-Health Policy
CiteScore
2.40
自引率
7.70%
发文量
47
审稿时长
65 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信